Online inquiry

IVTScrip™ mRNA-Human ANKRD32, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17918MR)

This product GTTS-WK17918MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD32 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_032290.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 84250
UniProt ID Q9BQI6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD32, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17918MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK13406MR IVTScrip™ mRNA-Human ADAMTS7, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADAMTS7
GTTS-WK6319MR IVTScrip™ mRNA-Human RUNX2, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA RUNX2
GTTS-WK9544MR IVTScrip™ mRNA-Human ADGRG6, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADGRG6
GTTS-WK8828MR IVTScrip™ mRNA-Human ACKR4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACKR4
GTTS-WK17910MR IVTScrip™ mRNA-Human ANKRD20A9P, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD20A9P
GTTS-WK22679MR IVTScrip™ mRNA-Human ARRDC2, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARRDC2
GTTS-WK22647MR IVTScrip™ mRNA-Human ARL6IP1, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARL6IP1
GTTS-WK23522MR IVTScrip™ mRNA-Human ARHGEF7, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF7
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →